Appropriate Billing of MBS Item 13950

The intent for item 13950 is to provide services through Medicare for private patients undergoing antineoplastic therapy. Specifically, Medicare benefits will be paid under item 13950 where the patient is administered with an antineoplastic agent or agents via parenteral route, by or on behalf of a specialist or consultant physician, for antineoplastic treatment (including; cytotoxic chemotherapy and monoclonal antibody therapy).

Item 13950 is not intended for treatment via the administration of agents used in anti-resorptive bone therapy or hormonal therapy.

PDF version Chemotherapy Procedures Appropriate Claiming of Item 13950 (PDF 168 KB)
Word version Chemotherapy Procedures Appropriate Claiming of Item 13950 (Word 37 KB)